Sara Consalvi

656 total citations
27 papers, 507 citations indexed

About

Sara Consalvi is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Sara Consalvi has authored 27 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Infectious Diseases and 7 papers in Organic Chemistry. Recurrent topics in Sara Consalvi's work include Tuberculosis Research and Epidemiology (7 papers), Biochemical and Molecular Research (6 papers) and Inflammatory mediators and NSAID effects (6 papers). Sara Consalvi is often cited by papers focused on Tuberculosis Research and Epidemiology (7 papers), Biochemical and Molecular Research (6 papers) and Inflammatory mediators and NSAID effects (6 papers). Sara Consalvi collaborates with scholars based in Italy, Spain and United States. Sara Consalvi's co-authors include Mariangela Biava, Giovanna Poce, Salvatore Alfonso, Carla Ghelardini, Lorenzo Di Cesare Mannelli, Antonio Giordani, Ilaria Peluso, Paola Patrignani, Elisabetta Toti and Anna Raguzzini and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Seminars in Cancer Biology.

In The Last Decade

Sara Consalvi

26 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Consalvi Italy 13 199 185 123 87 68 27 507
Céline Crauste France 17 200 1.0× 296 1.6× 156 1.3× 41 0.5× 84 1.2× 36 688
Shalki Choudhary India 13 210 1.1× 192 1.0× 116 0.9× 91 1.0× 32 0.5× 38 641
Jana Mandíková Czechia 14 226 1.1× 198 1.1× 90 0.7× 129 1.5× 66 1.0× 25 517
Kamal Ahmad India 14 270 1.4× 228 1.2× 71 0.6× 64 0.7× 51 0.8× 40 591
Priya Wazir India 14 70 0.4× 161 0.9× 58 0.5× 108 1.2× 23 0.3× 31 385
Julie Charton France 17 276 1.4× 472 2.6× 126 1.0× 53 0.6× 199 2.9× 43 1.1k
Leonardo Baldassarre Italy 12 103 0.5× 272 1.5× 47 0.4× 74 0.9× 12 0.2× 14 476
Thadeu Estevam Moreira Maramaldo Costa Brazil 13 180 0.9× 225 1.2× 36 0.3× 34 0.4× 57 0.8× 21 574
Daniela Hartmann Jornada Brazil 4 151 0.8× 149 0.8× 28 0.2× 30 0.3× 97 1.4× 6 441
Youmei Peng China 13 65 0.3× 169 0.9× 133 1.1× 31 0.4× 63 0.9× 29 525

Countries citing papers authored by Sara Consalvi

Since Specialization
Citations

This map shows the geographic impact of Sara Consalvi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Consalvi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Consalvi more than expected).

Fields of papers citing papers by Sara Consalvi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Consalvi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Consalvi. The network helps show where Sara Consalvi may publish in the future.

Co-authorship network of co-authors of Sara Consalvi

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Consalvi. A scholar is included among the top collaborators of Sara Consalvi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Consalvi. Sara Consalvi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Biava, Mariangela, et al.. (2024). Amino Acid Biosynthesis Inhibitors in Tuberculosis Drug Discovery. Pharmaceutics. 16(6). 725–725. 2 indexed citations
2.
Consalvi, Sara, Mariangela Biava, Alessia Ciogli, et al.. (2024). SAR Analysis of Novel Coxsackie virus A9 Capsid Binders. Journal of Medicinal Chemistry. 67(19). 17144–17161.
3.
Fiorentino, Francesco, et al.. (2024). Transmission-Blocking Strategies for Malaria Eradication: Recent Advances in Small-Molecule Drug Development. Pharmaceuticals. 17(7). 962–962. 3 indexed citations
4.
Consalvi, Sara, Olivier Sheik Amamuddy, Özlem Taştan Bishop, et al.. (2023). Antiviral Mechanisms of N-Phenyl Benzamides on Coxsackie Virus A9. Pharmaceutics. 15(3). 1028–1028. 4 indexed citations
5.
Biava, Mariangela, et al.. (2023). Direct-Acting Antivirals and Host-Targeting Approaches against Enterovirus B Infections: Recent Advances. Pharmaceuticals. 16(2). 203–203. 12 indexed citations
6.
Consalvi, Sara, Junhao Zhu, Helena I. Boshoff, et al.. (2021). 6-Fluorophenylbenzohydrazides inhibit Mycobacterium tuberculosis growth through alteration of tryptophan biosynthesis. European Journal of Medicinal Chemistry. 226. 113843–113843. 3 indexed citations
7.
Consalvi, Sara, Emanuela Berrino, Marialucia Gallorini, et al.. (2021). A Novel Class of Dual-Acting DCH-CORMs Counteracts Oxidative Stress-Induced Inflammation in Human Primary Tenocytes. Antioxidants. 10(11). 1828–1828. 4 indexed citations
8.
Consalvi, Sara, et al.. (2020). SAR Analysis of Small Molecules Interfering with Energy-Metabolism in Mycobacterium tuberculosis. Pharmaceuticals. 13(9). 227–227. 15 indexed citations
9.
Consalvi, Sara, Giovanna Poce, Carla Ghelardini, et al.. (2020). Therapeutic potential for coxibs-nitric oxide releasing hybrids in cystic fibrosis. European Journal of Medicinal Chemistry. 210. 112983–112983. 4 indexed citations
10.
Aiello, Paola, Sara Consalvi, Giovanna Poce, et al.. (2019). Dietary flavonoids: Nano delivery and nanoparticles for cancer therapy. Seminars in Cancer Biology. 69. 150–165. 89 indexed citations
11.
Consalvi, Sara, et al.. (2019). Mycobacterial tryptophan biosynthesis: A promising target for tuberculosis drug development?. Bioorganic & Medicinal Chemistry Letters. 29(23). 126731–126731. 10 indexed citations
12.
Poce, Giovanna, Salvatore Alfonso, Sara Consalvi, et al.. (2017). In vivo potent BM635 analogue with improved drug-like properties. European Journal of Medicinal Chemistry. 145. 539–550. 21 indexed citations
13.
Poce, Giovanna, Sara Consalvi, Robert H. Bates, et al.. (2016). Pharmaceutical salt of BM635 with improved bioavailability. European Journal of Pharmaceutical Sciences. 99. 17–23. 12 indexed citations
14.
Consalvi, Sara, Mariangela Biava, & Giovanna Poce. (2015). COX inhibitors: a patent review (2011 – 2014). Expert Opinion on Therapeutic Patents. 25(12). 1357–1371. 36 indexed citations
15.
Consalvi, Sara, Salvatore Alfonso, Angela Di Capua, et al.. (2014). Synthesis, biological evaluation and docking analysis of a new series of methylsulfonyl and sulfamoyl acetamides and ethyl acetates as potent COX-2 inhibitors. Bioorganic & Medicinal Chemistry. 23(4). 810–820. 23 indexed citations
16.
Poce, Giovanna, et al.. (2014). SAR analysis of new anti-TB drugs currently in pre-clinical and clinical development. European Journal of Medicinal Chemistry. 86. 335–351. 44 indexed citations
18.
Biava, Mariangela, Claudio Battilocchio, Giovanna Poce, et al.. (2013). Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors. Bioorganic & Medicinal Chemistry. 22(2). 772–786. 21 indexed citations
19.
Battilocchio, Claudio, Giovanna Poce, Salvatore Alfonso, et al.. (2013). A class of pyrrole derivatives endowed with analgesic/anti-inflammatory activity. Bioorganic & Medicinal Chemistry. 21(13). 3695–3701. 77 indexed citations
20.
Biava, Mariangela, Claudio Battilocchio, Giovanna Poce, et al.. (2012). Improving the solubility of a new class of antiinflammatory pharmacodynamic hybrids, that release nitric oxide and inhibit cycloxygenase-2 isoenzyme. European Journal of Medicinal Chemistry. 58. 287–298. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026